Delivery Order SPE2DB22D3016-SPE2DB24FBFE7
Award Date
8/26/24
Potential Completion Date
9/17/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,565.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical product, with a period of performance ending on December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $4,917.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a medical product, with a completion date of July 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award is a delivery order valued at $4,917.64, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a performance period extending through May 23, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,752.92, is a delivery order for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has a completion date of February 3, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,688.23 delivery order contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is a delivery order for the product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. It is a firm fixed-price contract with a completion date of June 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,917.64 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,917.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of January 24, 2025 and is structured as a firm fixed-price delivery order. The award is not associated with any set-aside requirements. AmerisourceBergen...
This federal contract award, valued at $4,753.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The award has an ultimate completion date of November 12, 2024 and a firm fixed price pricing type. This contract is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The $2,376.70 firm fixed price contract has a completion date of November 14, 2024. This appears to be a delivery order against an existing Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA...